Provided by Tiger Fintech (Singapore) Pte. Ltd.

SELLAS Life Sciences Group Inc.

1.80
-0.0300-1.64%
Post-market: 1.820.0200+1.11%19:59 EDT
Volume:1.01M
Turnover:1.84M
Market Cap:179.60M
PE:-4.77
High:1.86
Open:1.84
Low:1.78
Close:1.83
Loading ...

SELLAS Life Sciences Is Maintained at Buy by Maxim Group

Dow Jones
·
17 Jul

Maxim Group Keeps Their Buy Rating on SELLAS Life Sciences Group (SLS)

TIPRANKS
·
16 Jul

Sellas Life Sciences Meets Primary Endpoints in Mid-Stage SLS009 Trial

MT Newswires Live
·
15 Jul

Sellas Life Sciences meets all primary endpoints in Phase 2 trial of SLS009

TIPRANKS
·
15 Jul

SELLAS Meets All Primary Endpoints in Phase 2 Trial of SLS009 in r/r AML and Receives FDA Guidance to Advance into First-Line Therapy Study

GlobeNewswire
·
15 Jul

Sellas Life Sciences appoints Linghua Wang to Scientific Advisory Board

TIPRANKS
·
07 Jul

Press Release: SELLAS Life Sciences Appoints Linghua Wang, MD, PhD, to Scientific Advisory Board

Dow Jones
·
07 Jul

Sellas Life Sciences Group to Join Russell 3000, 2000 Indexes

MT Newswires Live
·
24 Jun

Sellas Life Sciences Group Inc. Conducted Annual Stockholders Meeting

Reuters
·
19 Jun

Director Robert L. Van Nostrand Reports Acquisition of Common Shares of Sellas Life Sciences Group Inc

Reuters
·
13 Jun

Sellas Life Sciences Appoints Baker Tilly as New Auditors Following Moss Adams Merger

Reuters
·
07 Jun

Senate Republicans Seek to Protect NASA Programs Targeted for Cuts -- 2nd Update

Dow Jones
·
06 Jun

Sellas Life Sciences expands SAB with Philip Amrein, Alex Kentsis

TIPRANKS
·
05 Jun

Press Release: SELLAS Life Sciences Expands Scientific Advisory Board with Addition of Two World-Renowned Hematology and Oncology Experts

Dow Jones
·
05 Jun

Director Jane Wasman Reports Acquisition of Common Shares in Sellas Life Sciences Group Inc

Reuters
·
03 Jun

Director Katherine Bach Kalin Acquires Common Shares of Sellas Life Sciences Group Inc

Reuters
·
23 May

Sellas Life Sciences Doses 1st Pediatric Patient in Acute Myeloid Leukemia Study

MT Newswires Live
·
15 May

Sellas Life Sciences Group Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
14 May

SELLAS Life Sciences Gr Q1 EPS $(0.07) Beats $(0.10) Estimate

Benzinga
·
14 May

SELLAS Life Sciences Q1 Net Income USD -5.813 Million

Reuters
·
14 May